124. 125. 126. Crile, G. Jr. Changing end results in patients with papillary carci- noma of the thyroid. Surg. Gynecol. Obstet. 132: 460-8 (1971). Hazard, J.B., Crile, G. Jr., and Dempsey, W.S. osing tumors of the thyroid. Nonencapsulated scler- J. Clin. Endocrinol. 9: 1215 (1949). Franssila, K.O. Prognosis in thyroid carcinoma. Cancer 36: 1138-46 (1975). Hazard, J.B. Small papillary carcinoma of the thyroid: A study with Special reference to so-cailed nonencapsulated sclerosing tumor. Invest. 9: 86-97 (1960). Lab. 127. Klinck, G.B. and Winship, T. 128. Williams, E.D. The pathology of thyroid malignancy. Br. J. Surg. 62: 757-9 (1975). Sampson, R.J., Oka, H., Key, C.R., Bunmcher, C.R., and Iijima, S. Metastases from occult thyroid carcinoma: An autopsy study fcom 129. 130. 131. 132. 133. 134. 135. 136. 137. 138. 139. 140. roid. Cancer 8: 701 (1955). Hiroshima and Nagasaki, Japan. Fukunaga, F.H. and Yatani, R. carcinomas. Occult sclerosing carcinoma of the thy- Cancer 25: 803-11 (1970). Geographic pathology of occult thyroid Cancer 36: 1095-9 (1975). Sawin, C.T. and Hershman, J.M. The TSH response to thyrotropin- releasing hormone (TRH) in voung adult men: Intra~individual variation and relation to basal serum TSH and thyroid hormones. J. Clin. Endocrinol. Metab. 46: 217 (1978). Thein-Wai, W. and Larsen, P.R. Effects of weekly thyroxine administration on serum thyroxine and 3,5,3'-triiodothyronine, thyrotropin and thyrotropin response to thyrotropin-releasing hormone. J. Clin. Endocrinol. Metab. 50: 660 (1980). Tunbridge, W.M.G., Evered, D.C., Hall, R., Appleton, D., Brewis, M., Clark, F., Grimley Evans, J., Young, E., Bird, T., and Smith, P.A. The spectrum of thyroid disease in a commnity: The Wickham survey. Clin. Endocrinol. 7: 481 (1977). Van Middlesworth, L. Factors influencing the thyroid uptake of iodine isotopes from nuclear fission: A review. Health Phys. 9: 1197-1211 (1963). Evans, T.C., Kretzchmar, R.H., Hodges, R.E., and Song, C.W. Radioiodine uptake studies of the human fetal thyroid. J. Nucl. Med. 8: 157-60 (1967). Hodges, R.E., Evans, T.C., Bradbury, J.T., and Keettel, W.C. mulation of radioactive iodine by human fetal thyroids. Endocrinol. Metab. 15: 661-7 (1955). Mays, C.W. The accu- J. Clin. (University of Utah), Personal communication, 1974. Russel, K.P., Rowse, H., and Starr, P. The effects of radioactive iodine in maternal and fetal thyroid function during pregnancy. Surg. Gynecol. Obstet. 104: 560-4 (1957). Fisher, W.D., Voorhess, M.L., and Gardner, L.I. Congenital hypothyroidism in infant following maternal qi31 therapy. with a review of hazards of environmental radioisotope contamination. J. Pediat. 62: 132-46 (1963). Hamill, G.C., Jarman, J.A., and Wynne, M.D. Fetal effects of radio- active iodine therapy in a pregnant woman with thyroid cancer. Obstet. Gynecol. 81: 1018-23 (1961). - 96 _ SEE Am. J. - _—- 123.